JONES WILLIAM A JR 4
4 · NewAmsterdam Pharma Co N.V. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
JONES WILLIAM A JR
Chief Commercial Officer
Transactions
- Award
Option (right to buy)
2025-01-02+200,000→ 200,000 totalExercise: $25.96Exp: 2035-01-02→ Ordinary Shares (200,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option will vest on January 2, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.